Cipla boosts investment in Ethris to advance mRNA therapies in emerging markets
Cipla Limited has announced an additional investment of EUR 3 million in Ethris GmbH, further strengthening its involvement in the mRNA technology sector. This move ... Read More
Sanofi India partners with Cipla Limited for enhanced distribution of CNS product range
In a strategic move poised to reshape the landscape of Central Nervous System (CNS) medication accessibility in India, Sanofi India Limited (SIL) and Cipla Limited ... Read More
Cipla Limited’s subsidiary InvaGen Pharmaceuticals recalls Vigabatrin Oral Solution
In an important safety announcement, Cipla Limited revealed that its wholly-owned subsidiary, InvaGen Pharmaceuticals Inc., based in the USA, is conducting a voluntary recall of ... Read More